Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: a long-term mono-center study
暂无分享,去创建一个
S. Nakasu | Y. Nakasu | K. Mori | T. Ikeda | K. Mitsuya | I. Okamura | N. Hayashi | R. Tatara | T. Enami